DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/58w95m/back_pain) has announced the addition of the "Back Pain - Pipeline Review, H1 2013" report to their offering.
'Back Pain - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Back Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Back Pain.
Scope
- A snapshot of the global therapeutic scenario for Back Pain.
- A review of the Back Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Back Pain pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Companies Involved in Back Pain Therapeutics Development
-
DURECT Corporation
-
BioDelivery Sciences International, Inc.
-
Zogenix, Inc.
-
Eisai Co., Ltd.
-
Purdue Pharma L.P.
-
Teva Pharmaceutical Industries Limited
-
Collegium Pharmaceutical, Inc.
-
Mesoblast Ltd
-
Newron Pharmaceuticals S.p.A.
-
Teikoku Pharma USA, Inc.
-
Grunenthal GmbH
-
QRxPharma Limited
-
Sosei Co. Ltd.
-
Troikaa Pharmaceuticals Ltd.
Drug Profiles
- hydrocodone bitartrate ER
- (acetaminophen + hydrocodone bitartrate) CR
- ABT-110
- bupivacaine Trandermal
- buprenorphine hydrochloride
- (morphine sulfate + oxycodone) CR
- Priralfinamide
- cebranopadol
- cycloserine
- hydrocodone bitartrate ER
- SD-726
- oxycodone ER
- Benztropine
- TPH-023
- zoledronic acid
- diclofenac sodium + eperisone
- Mesenchymal Precursor Cells For Chronic Back Pain
- REC-1100
- hydrocodone bitartrate
- ATNC-05
- (diclofenac sodium + thiocolchicoside)
- T-109
- AYX-2
- NuQu Cell-Based Therapy
- AKR-202
- AKR-203
For more information visit http://www.researchandmarkets.com/research/58w95m/back_pain
